2022 annual financial data
Quince Therapeutics 2022 Net margin
Direct answer
Net margin was Not calculable.
Operating income was -52,015,000 USD and net income was -51,660,000 USD.
Operating cash flow was -44,038,000 USD.
Get free Quince Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -52,015,000 USD
- Net income
- -51,660,000 USD
- Operating cash flow
- -44,038,000 USD